| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | NUP98 SHANK1 KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 NUP214 KRT14 KRT76 KRT24 NUP58 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.53e-23 | 891 | 38 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT76 KRT75 KRT6C KRT77 | 1.32e-21 | 43 | 38 | 11 | GO:0030280 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.49e-09 | 130 | 38 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.42e-05 | 25 | 38 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.80e-05 | 27 | 38 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 1.24e-04 | 51 | 38 | 3 | GO:0005048 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.68e-04 | 276 | 38 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | mRNA binding | 2.93e-04 | 694 | 38 | 7 | GO:0003729 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 5.91e-04 | 19 | 38 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.22e-03 | 111 | 38 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 2.89e-03 | 42 | 38 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 4.40e-03 | 52 | 38 | 2 | GO:0035255 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 6.21e-03 | 62 | 38 | 2 | GO:0061980 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 3.26e-40 | 75 | 38 | 20 | GO:0045109 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.70e-37 | 99 | 38 | 20 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 2.13e-37 | 100 | 38 | 20 | GO:0045103 |
| GeneOntologyBiologicalProcess | keratinization | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT76 KRT16 KRT75 KRT17 KRT6C KRT77 | 3.57e-20 | 87 | 38 | 12 | GO:0031424 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHANK1 KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 FUS KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 3.99e-20 | 957 | 38 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT14 KRT76 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.44e-19 | 189 | 38 | 14 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermis development | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.21e-18 | 461 | 38 | 17 | GO:0008544 |
| GeneOntologyBiologicalProcess | skin development | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT14 KRT76 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.47e-18 | 373 | 38 | 16 | GO:0043588 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 4.20e-18 | 870 | 38 | 20 | GO:0030855 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT14 KRT76 KRT16 KRT75 KRT17 KRT6C KRT77 | 4.60e-17 | 284 | 38 | 14 | GO:0009913 |
| GeneOntologyBiologicalProcess | epithelium development | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B TEAD2 KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 6.22e-15 | 1469 | 38 | 21 | GO:0060429 |
| GeneOntologyBiologicalProcess | mRNA transport | 2.50e-07 | 145 | 38 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 7.54e-07 | 175 | 38 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 7.54e-07 | 175 | 38 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 8.33e-07 | 178 | 38 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | RNA localization | 2.64e-06 | 217 | 38 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 5.82e-06 | 249 | 38 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.43e-05 | 443 | 38 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 1.64e-05 | 27 | 38 | 3 | GO:0018149 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 2.88e-05 | 96 | 38 | 4 | GO:0006405 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.19e-04 | 619 | 38 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | molting cycle | 1.64e-04 | 150 | 38 | 4 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 1.64e-04 | 150 | 38 | 4 | GO:0042633 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.88e-04 | 292 | 38 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 2.41e-04 | 308 | 38 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 2.41e-04 | 166 | 38 | 4 | GO:0098773 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 2.44e-04 | 309 | 38 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of translation | 2.64e-04 | 494 | 38 | 6 | GO:0006417 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.64e-04 | 185 | 38 | 4 | GO:0051168 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.84e-04 | 77 | 38 | 3 | GO:0048255 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 3.85e-04 | 750 | 38 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 3.90e-04 | 16 | 38 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 4.42e-04 | 17 | 38 | 2 | GO:0003334 | |
| GeneOntologyBiologicalProcess | import into nucleus | 4.98e-04 | 201 | 38 | 4 | GO:0051170 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 5.50e-04 | 87 | 38 | 3 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 5.68e-04 | 88 | 38 | 3 | GO:0043489 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 5.79e-04 | 373 | 38 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | nuclear transport | 6.14e-04 | 378 | 38 | 5 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 6.14e-04 | 378 | 38 | 5 | GO:0006913 | |
| GeneOntologyBiologicalProcess | keratinocyte migration | 6.79e-04 | 21 | 38 | 2 | GO:0051546 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 8.49e-04 | 101 | 38 | 3 | GO:1902369 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.01e-03 | 1153 | 38 | 8 | GO:0010608 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.12e-03 | 432 | 38 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.24e-03 | 115 | 38 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.27e-03 | 917 | 38 | 7 | GO:0016071 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.28e-03 | 259 | 38 | 4 | GO:1903313 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 1.49e-03 | 31 | 38 | 2 | GO:0051291 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.53e-03 | 464 | 38 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 1.68e-03 | 33 | 38 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 2.09e-03 | 296 | 38 | 4 | GO:0051259 | |
| GeneOntologyBiologicalProcess | RNA splicing | 2.17e-03 | 502 | 38 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | regulation of nucleocytoplasmic transport | 2.26e-03 | 142 | 38 | 3 | GO:0046822 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 2.47e-03 | 40 | 38 | 2 | GO:0031069 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 2.59e-03 | 41 | 38 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.69e-03 | 151 | 38 | 3 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 3.06e-03 | 158 | 38 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 3.25e-03 | 46 | 38 | 2 | GO:0048730 | |
| GeneOntologyBiologicalProcess | translation | 3.69e-03 | 824 | 38 | 6 | GO:0006412 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 5.50e-03 | 195 | 38 | 3 | GO:0006606 | |
| GeneOntologyCellularComponent | intermediate filament | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 6.27e-30 | 227 | 38 | 20 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.30e-28 | 263 | 38 | 20 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 KRT16 KRT75 KRT17 KRT6C KRT77 | 2.58e-28 | 97 | 38 | 16 | GO:0045095 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 6.14e-18 | 899 | 38 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.15e-15 | 1179 | 38 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.31e-15 | 1187 | 38 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | cornified envelope | 4.19e-13 | 69 | 38 | 8 | GO:0001533 | |
| GeneOntologyCellularComponent | nuclear pore | 8.17e-04 | 101 | 38 | 3 | GO:0005643 | |
| HumanPheno | Palmoplantar blistering | 3.51e-13 | 11 | 18 | 6 | HP:0007446 | |
| HumanPheno | Palmoplantar hyperkeratosis | 2.82e-12 | 129 | 18 | 10 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 3.30e-12 | 131 | 18 | 10 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 3.56e-12 | 132 | 18 | 10 | HP:0007556 | |
| HumanPheno | Hyperkeratosis | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT6C | 3.49e-11 | 233 | 18 | 11 | HP:0000962 |
| HumanPheno | Palmoplantar keratoderma | 4.21e-11 | 114 | 18 | 9 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 4.56e-11 | 115 | 18 | 9 | HP:0008066 | |
| HumanPheno | Abnormality of the plantar skin of foot | 4.86e-11 | 171 | 18 | 10 | HP:0100872 | |
| HumanPheno | Abnormality of keratinization | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT6C | 5.77e-11 | 244 | 18 | 11 | HP:0001035 |
| HumanPheno | Steatocystoma multiplex | 1.09e-10 | 4 | 18 | 4 | HP:0012035 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 1.09e-10 | 4 | 18 | 4 | HP:0007475 | |
| HumanPheno | Eruptive vellus hair cyst | 1.09e-10 | 4 | 18 | 4 | HP:0025248 | |
| HumanPheno | Blistering by anatomical location | 1.70e-10 | 26 | 18 | 6 | HP:0033800 | |
| HumanPheno | White lesion of the oral mucosa | 2.76e-10 | 28 | 18 | 6 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 2.76e-10 | 28 | 18 | 6 | HP:0002745 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 5.45e-10 | 5 | 18 | 4 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 5.45e-10 | 5 | 18 | 4 | HP:0030268 | |
| HumanPheno | Onychogryposis of toenails | 3.80e-09 | 7 | 18 | 4 | HP:0008401 | |
| HumanPheno | Onychogryposis | 3.80e-09 | 7 | 18 | 4 | HP:0001819 | |
| HumanPheno | Epidermal thickening | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT6C | 6.65e-09 | 379 | 18 | 11 | HP:0011368 |
| HumanPheno | Onychogryposis of fingernail | 1.36e-08 | 9 | 18 | 4 | HP:0040036 | |
| HumanPheno | Abnormal epidermal morphology | 1.57e-08 | 94 | 18 | 7 | HP:0011124 | |
| HumanPheno | Epidermal acanthosis | 1.80e-08 | 54 | 18 | 6 | HP:0025092 | |
| HumanPheno | Thickened skin | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT6C | 2.59e-08 | 431 | 18 | 11 | HP:0001072 |
| HumanPheno | Onychogryposis | 3.39e-08 | 29 | 18 | 5 | HP:0001805 | |
| HumanPheno | Angular cheilitis | 5.31e-08 | 12 | 18 | 4 | HP:0030318 | |
| HumanPheno | Palmoplantar hyperhidrosis | 1.07e-07 | 14 | 18 | 4 | HP:0007410 | |
| HumanPheno | Ear pain | 1.45e-07 | 15 | 18 | 4 | HP:0030766 | |
| HumanPheno | Fingernail dysplasia | 1.94e-07 | 16 | 18 | 4 | HP:0100798 | |
| HumanPheno | Palmar hyperhidrosis | 1.94e-07 | 16 | 18 | 4 | HP:0006089 | |
| HumanPheno | Paronychia | 1.94e-07 | 16 | 18 | 4 | HP:0001818 | |
| HumanPheno | Lower limb pain | 2.08e-07 | 41 | 18 | 5 | HP:0012514 | |
| HumanPheno | Abnormal skin morphology of the palm | 2.67e-07 | 413 | 18 | 10 | HP:0040211 | |
| HumanPheno | Hypergranulosis | 7.68e-07 | 22 | 18 | 4 | HP:0025114 | |
| HumanPheno | Abnormality of the periungual region | 7.68e-07 | 22 | 18 | 4 | HP:0100803 | |
| HumanPheno | Hyperhidrosis | 8.43e-07 | 167 | 18 | 7 | HP:0000975 | |
| HumanPheno | Limb pain | 1.13e-06 | 57 | 18 | 5 | HP:0009763 | |
| HumanPheno | Knuckle pad | 2.05e-06 | 8 | 18 | 3 | HP:0032541 | |
| HumanPheno | Abnormal palm morphology | 2.36e-06 | 521 | 18 | 10 | HP:0100871 | |
| HumanPheno | Follicular hyperkeratosis | 2.83e-06 | 30 | 18 | 4 | HP:0007502 | |
| HumanPheno | Regional abnormality of skin | 3.34e-06 | 541 | 18 | 10 | HP:0011356 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 4.19e-06 | 33 | 18 | 4 | HP:0007431 | |
| HumanPheno | Epidermal hyperkeratosis | 6.01e-06 | 11 | 18 | 3 | HP:0007543 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 6.01e-06 | 11 | 18 | 3 | HP:0007447 | |
| HumanPheno | Abnormal fingernail morphology | 7.26e-06 | 230 | 18 | 7 | HP:0001231 | |
| HumanPheno | Natal tooth | 7.48e-06 | 38 | 18 | 4 | HP:0000695 | |
| HumanPheno | Supernumerary tooth | 8.30e-06 | 85 | 18 | 5 | HP:0011069 | |
| HumanPheno | Hypohidrosis or hyperhidrosis | 8.37e-06 | 235 | 18 | 7 | HP:0007550 | |
| HumanPheno | Pain in head and neck region | 9.22e-06 | 40 | 18 | 4 | HP:0046506 | |
| HumanPheno | Nail dystrophy | 1.03e-05 | 156 | 18 | 6 | HP:0008404 | |
| HumanPheno | Abnormality of skin adnexa physiology | 1.23e-05 | 249 | 18 | 7 | HP:0025276 | |
| HumanPheno | Epidermoid cyst | 1.49e-05 | 45 | 18 | 4 | HP:0200040 | |
| HumanPheno | Advanced eruption of teeth | 1.62e-05 | 46 | 18 | 4 | HP:0006288 | |
| HumanPheno | Abnormal sweat gland morphology | 1.63e-05 | 260 | 18 | 7 | HP:0000971 | |
| HumanPheno | Cutaneous cyst | 2.46e-05 | 51 | 18 | 4 | HP:0025245 | |
| HumanPheno | Cheilitis | 4.11e-05 | 58 | 18 | 4 | HP:0100825 | |
| HumanPheno | Hyperparakeratosis | 7.05e-05 | 4 | 18 | 2 | HP:0040009 | |
| HumanPheno | Skin erosion | 1.15e-04 | 28 | 18 | 3 | HP:0200041 | |
| HumanPheno | Dyspnea | 1.59e-04 | 506 | 18 | 8 | HP:0002094 | |
| HumanPheno | Hoarse voice | 1.71e-04 | 159 | 18 | 5 | HP:0001609 | |
| HumanPheno | Abnormal nail morphology | 1.83e-04 | 516 | 18 | 8 | HP:0001597 | |
| HumanPheno | Abnormal oral mucosa morphology | 1.91e-04 | 381 | 18 | 7 | HP:0011830 | |
| HumanPheno | Nail dysplasia | 2.00e-04 | 264 | 18 | 6 | HP:0002164 | |
| HumanPheno | Abnormality of temperature sensation | 2.07e-04 | 34 | 18 | 3 | HP:0100772 | |
| HumanPheno | Impaired temperature sensation | 2.07e-04 | 34 | 18 | 3 | HP:0010829 | |
| HumanPheno | Subungual hyperkeratosis | 2.45e-04 | 7 | 18 | 2 | HP:0008392 | |
| HumanPheno | Impaired tactile sensation | 2.67e-04 | 37 | 18 | 3 | HP:0010830 | |
| HumanPheno | Abnormality of the voice | 2.69e-04 | 545 | 18 | 8 | HP:0001608 | |
| HumanPheno | Progressive distal muscular atrophy | 2.89e-04 | 38 | 18 | 3 | HP:0008955 | |
| HumanPheno | Jaw hyperreflexia | 3.63e-04 | 41 | 18 | 3 | HP:0033683 | |
| HumanPheno | Fatigable weakness of swallowing muscles | 3.90e-04 | 42 | 18 | 3 | HP:0030195 | |
| HumanPheno | Laryngospasm | 3.90e-04 | 42 | 18 | 3 | HP:0025425 | |
| HumanPheno | Hoffmann sign | 5.12e-04 | 46 | 18 | 3 | HP:0031993 | |
| HumanPheno | Abnormal larynx physiology | 5.80e-04 | 48 | 18 | 3 | HP:0025424 | |
| HumanPheno | Amyotrophic lateral sclerosis | 6.17e-04 | 49 | 18 | 3 | HP:0007354 | |
| HumanPheno | Conjunctival nodule | 6.37e-04 | 11 | 18 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 6.37e-04 | 11 | 18 | 2 | HP:0100780 | |
| HumanPheno | Tongue atrophy | 7.35e-04 | 52 | 18 | 3 | HP:0012473 | |
| HumanPheno | Frontotemporal dementia | 7.35e-04 | 52 | 18 | 3 | HP:0002145 | |
| HumanPheno | Abnormality of the subungual region | 7.62e-04 | 12 | 18 | 2 | HP:0009723 | |
| HumanPheno | Xerostomia | 8.67e-04 | 55 | 18 | 3 | HP:0000217 | |
| HumanPheno | Respiratory distress | 8.76e-04 | 226 | 18 | 5 | HP:0002098 | |
| HumanPheno | Hyperkeratotic papule | 8.99e-04 | 13 | 18 | 2 | HP:0045059 | |
| HumanPheno | Fatigable weakness of respiratory muscles | 1.01e-03 | 58 | 18 | 3 | HP:0030196 | |
| HumanPheno | Erythema | 1.02e-03 | 133 | 18 | 4 | HP:0010783 | |
| HumanPheno | Abnormality of the larynx | 1.07e-03 | 666 | 18 | 8 | HP:0001600 | |
| HumanPheno | Upper-limb joint contracture | 1.10e-03 | 362 | 18 | 6 | HP:0100360 | |
| HumanPheno | Fatigable weakness of bulbar muscles | 1.17e-03 | 61 | 18 | 3 | HP:0030192 | |
| HumanPheno | Ichthyosis | 1.38e-03 | 144 | 18 | 4 | HP:0008064 | |
| HumanPheno | Motor neuron atrophy | 1.48e-03 | 66 | 18 | 3 | HP:0007373 | |
| HumanPheno | Localized skin lesion | 1.66e-03 | 897 | 18 | 9 | HP:0011355 | |
| HumanPheno | Alopecia | 1.68e-03 | 261 | 18 | 5 | HP:0001596 | |
| HumanPheno | Clubbing | 1.68e-03 | 152 | 18 | 4 | HP:0001217 | |
| HumanPheno | Tongue fasciculations | 2.05e-03 | 74 | 18 | 3 | HP:0001308 | |
| HumanPheno | Orthokeratosis | 2.16e-03 | 20 | 18 | 2 | HP:0040162 | |
| HumanPheno | Neoplasm by anatomical site | 2.71e-03 | 959 | 18 | 9 | HP:0011793 | |
| HumanPheno | Abnormal conjunctiva morphology | 2.88e-03 | 176 | 18 | 4 | HP:0000502 | |
| HumanPheno | Joint contracture of the hand | 2.93e-03 | 296 | 18 | 5 | HP:0009473 | |
| HumanPheno | Dyscalculia | 3.11e-03 | 24 | 18 | 2 | HP:0002442 | |
| HumanPheno | Neurodegeneration | 3.16e-03 | 86 | 18 | 3 | HP:0002180 | |
| MousePheno | abnormal tongue epithelium morphology | 3.53e-09 | 27 | 32 | 5 | MP:0000764 | |
| MousePheno | abnormal epidermal layer morphology | 6.43e-09 | 271 | 32 | 9 | MP:0001216 | |
| MousePheno | abnormal esophagus morphology | 7.23e-09 | 66 | 32 | 6 | MP:0000467 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 1.58e-08 | 132 | 32 | 7 | MP:0001240 | |
| MousePheno | hyperkeratosis | 4.77e-08 | 90 | 32 | 6 | MP:0001242 | |
| MousePheno | abnormal keratinocyte morphology | 1.32e-07 | 54 | 32 | 5 | MP:0002655 | |
| MousePheno | blistering | 2.33e-07 | 24 | 32 | 4 | MP:0001208 | |
| MousePheno | abnormal tongue morphology | 2.41e-07 | 118 | 32 | 6 | MP:0000762 | |
| MousePheno | abnormal foot pad morphology | 3.26e-07 | 26 | 32 | 4 | MP:0000574 | |
| MousePheno | abnormal filiform papillae morphology | 3.79e-07 | 7 | 32 | 3 | MP:0000763 | |
| MousePheno | hyperpigmentation | 4.45e-07 | 28 | 32 | 4 | MP:0001188 | |
| MousePheno | acanthosis | 2.62e-06 | 43 | 32 | 4 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 3.15e-06 | 45 | 32 | 4 | MP:0009611 | |
| MousePheno | abnormal skin physiology | 3.17e-06 | 288 | 32 | 7 | MP:0005501 | |
| MousePheno | abnormal cornea epithelium thickness | 5.98e-06 | 16 | 32 | 3 | MP:0020853 | |
| MousePheno | abnormal esophageal epithelium morphology | 7.25e-06 | 17 | 32 | 3 | MP:0000468 | |
| MousePheno | abnormal skin morphology | SHANK1 KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 KRT76 KRT16 KRT27 | 8.29e-06 | 1455 | 32 | 13 | MP:0002060 |
| MousePheno | abnormal hair texture | 1.23e-05 | 63 | 32 | 4 | MP:0002074 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 1.39e-05 | 65 | 32 | 4 | MP:0001236 | |
| MousePheno | rough coat | 2.13e-05 | 24 | 32 | 3 | MP:0010179 | |
| MousePheno | abnormal skin pigmentation | 4.41e-05 | 87 | 32 | 4 | MP:0002095 | |
| MousePheno | esophageal epithelium hyperplasia | 5.06e-05 | 5 | 32 | 2 | MP:0000466 | |
| MousePheno | abnormal skin appearance | 7.84e-05 | 473 | 32 | 7 | MP:0009931 | |
| MousePheno | abnormal epidermis stratum basale morphology | 8.03e-05 | 37 | 32 | 3 | MP:0001231 | |
| MousePheno | abnormal pilosebaceous unit morphology | 9.42e-05 | 205 | 32 | 5 | MP:0030572 | |
| MousePheno | abnormal cornea epithelium morphology | 1.18e-04 | 42 | 32 | 3 | MP:0006000 | |
| MousePheno | increased cornea epithelium thickness | 1.41e-04 | 8 | 32 | 2 | MP:0020854 | |
| MousePheno | hypergranulosis | 1.81e-04 | 9 | 32 | 2 | MP:0009600 | |
| MousePheno | decreased cornea epithelium thickness | 1.81e-04 | 9 | 32 | 2 | MP:0020855 | |
| MousePheno | scaly skin | 2.64e-04 | 55 | 32 | 3 | MP:0001192 | |
| MousePheno | thick epidermis stratum granulosum | 3.30e-04 | 12 | 32 | 2 | MP:0009599 | |
| MousePheno | increased tail pigmentation | 3.30e-04 | 12 | 32 | 2 | MP:0011276 | |
| MousePheno | abnormal hair medulla | 3.90e-04 | 13 | 32 | 2 | MP:0003812 | |
| MousePheno | impaired skin barrier function | 4.13e-04 | 64 | 32 | 3 | MP:0002796 | |
| MousePheno | abnormal oral mucosa morphology | 4.54e-04 | 14 | 32 | 2 | MP:0003745 | |
| MousePheno | abnormal ocular surface morphology | 4.73e-04 | 67 | 32 | 3 | MP:0013754 | |
| MousePheno | abnormal intercostal muscle morphology | 5.23e-04 | 15 | 32 | 2 | MP:0002280 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 5.23e-04 | 15 | 32 | 2 | MP:0001233 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 5.37e-04 | 70 | 32 | 3 | MP:0001239 | |
| MousePheno | increased foot pigmentation | 5.97e-04 | 16 | 32 | 2 | MP:0030051 | |
| MousePheno | increased foot pad pigmentation | 5.97e-04 | 16 | 32 | 2 | MP:0000575 | |
| MousePheno | abnormal hair shaft morphology | 6.58e-04 | 75 | 32 | 3 | MP:0003809 | |
| MousePheno | abnormal mouth morphology | 6.63e-04 | 670 | 32 | 7 | MP:0000452 | |
| MousePheno | abnormal head morphology | 6.82e-04 | 1120 | 32 | 9 | MP:0000432 | |
| MousePheno | craniofacial phenotype | 6.87e-04 | 1372 | 32 | 10 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 6.87e-04 | 1372 | 32 | 10 | MP:0000428 | |
| MousePheno | abnormal skin coloration | 7.52e-04 | 182 | 32 | 4 | MP:0011239 | |
| MousePheno | abnormal corneocyte morphology | 7.59e-04 | 18 | 32 | 2 | MP:0030605 | |
| MousePheno | thick epidermis | 7.94e-04 | 80 | 32 | 3 | MP:0001219 | |
| MousePheno | abnormal keratinocyte physiology | 8.24e-04 | 81 | 32 | 3 | MP:0003453 | |
| MousePheno | flaky skin | 1.04e-03 | 21 | 32 | 2 | MP:0001195 | |
| MousePheno | waved hair | 1.04e-03 | 21 | 32 | 2 | MP:0000410 | |
| MousePheno | increased skin papilloma incidence | 1.14e-03 | 22 | 32 | 2 | MP:0002051 | |
| MousePheno | enlarged sebaceous gland | 1.25e-03 | 23 | 32 | 2 | MP:0000652 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.67e-03 | 1269 | 32 | 9 | MP:0011111 | |
| MousePheno | increased keratinocyte proliferation | 1.72e-03 | 27 | 32 | 2 | MP:0009583 | |
| MousePheno | abnormal autopod morphology | 1.78e-03 | 390 | 32 | 5 | MP:0000572 | |
| MousePheno | abnormal foot pigmentation | 1.85e-03 | 28 | 32 | 2 | MP:0009379 | |
| MousePheno | increased papilloma incidence | 2.56e-03 | 33 | 32 | 2 | MP:0002014 | |
| MousePheno | pigmentation phenotype | 2.59e-03 | 624 | 32 | 6 | MP:0001186 | |
| MousePheno | abnormal coat/ hair morphology | 2.71e-03 | 854 | 32 | 7 | MP:0000367 | |
| MousePheno | abnormal tail pigmentation | 3.57e-03 | 39 | 32 | 2 | MP:0005174 | |
| MousePheno | decreased food intake | 3.71e-03 | 137 | 32 | 3 | MP:0011940 | |
| MousePheno | abnormal facial morphology | 3.87e-03 | 910 | 32 | 7 | MP:0003743 | |
| MousePheno | abnormal keratinocyte proliferation | 3.94e-03 | 41 | 32 | 2 | MP:0009582 | |
| MousePheno | increased skin tumor incidence | 4.73e-03 | 45 | 32 | 2 | MP:0010300 | |
| Domain | IF | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 LZTS3 KRT6C KRT27 KRT77 | 8.27e-42 | 76 | 38 | 21 | IPR001664 |
| Domain | IF | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 9.20e-40 | 72 | 38 | 20 | PS00226 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.27e-39 | 73 | 38 | 20 | PF00038 |
| Domain | Intermediate_filament_CS | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.78e-38 | 63 | 38 | 19 | IPR018039 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 2.50e-37 | 71 | 38 | 19 | SM01391 |
| Domain | Keratin_I | KRT1 KRT3 KRT4 KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT17 KRT27 KRT77 | 3.85e-31 | 44 | 38 | 15 | IPR002957 |
| Domain | Keratin_II | 1.73e-21 | 26 | 38 | 10 | IPR003054 | |
| Domain | Keratin_2_head | 2.74e-19 | 24 | 38 | 9 | IPR032444 | |
| Domain | Keratin_2_head | 2.74e-19 | 24 | 38 | 9 | PF16208 | |
| Domain | Prefoldin | 1.46e-12 | 72 | 38 | 8 | IPR009053 | |
| Domain | GrpE_coiled_coil | 7.13e-09 | 12 | 38 | 4 | IPR013805 | |
| Domain | - | 1.80e-04 | 10 | 38 | 2 | 4.10.1060.10 | |
| Domain | DSRM | 6.74e-04 | 19 | 38 | 2 | SM00358 | |
| Domain | dsrm | 7.48e-04 | 20 | 38 | 2 | PF00035 | |
| Domain | DS_RBD | 8.26e-04 | 21 | 38 | 2 | PS50137 | |
| Domain | zf-RanBP | 9.08e-04 | 22 | 38 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 9.93e-04 | 23 | 38 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 9.93e-04 | 23 | 38 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 1.08e-03 | 24 | 38 | 2 | PS01358 | |
| Domain | HR1_rho-bd | 1.17e-03 | 25 | 38 | 2 | IPR011072 | |
| Domain | Znf_RanBP2 | 1.17e-03 | 25 | 38 | 2 | IPR001876 | |
| Domain | - | 1.37e-03 | 27 | 38 | 2 | 3.30.160.20 | |
| Domain | dsRBD_dom | 1.47e-03 | 28 | 38 | 2 | IPR014720 | |
| Domain | RRM_1 | 8.62e-03 | 208 | 38 | 3 | PF00076 | |
| Domain | RRM | 9.68e-03 | 217 | 38 | 3 | SM00360 | |
| Domain | RRM_dom | 1.09e-02 | 227 | 38 | 3 | IPR000504 | |
| Domain | RRM | 1.13e-02 | 230 | 38 | 3 | PS50102 | |
| Domain | - | 1.33e-02 | 244 | 38 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.54e-02 | 258 | 38 | 3 | IPR012677 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 2.36e-32 | 129 | 36 | 20 | M27649 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT27 KRT77 | 2.15e-31 | 87 | 36 | 18 | MM15351 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.35e-27 | 217 | 36 | 20 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT27 KRT77 | 1.20e-26 | 153 | 36 | 18 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT27 KRT77 | 3.15e-17 | 502 | 36 | 18 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B TEAD2 KRT9 KRT10 KRT12 CNOT11 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.13e-13 | 1432 | 36 | 22 | M509 |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 5.02e-08 | 40 | 36 | 5 | M48231 | |
| Pathway | WP_PANCREATIC_CANCER_SUBTYPES | 6.43e-06 | 48 | 36 | 4 | M48093 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.81e-05 | 151 | 36 | 5 | M550 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.47e-05 | 277 | 36 | 6 | MM15414 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 7.21e-05 | 32 | 36 | 3 | M29579 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.28e-05 | 283 | 36 | 6 | M13087 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 7.92e-05 | 33 | 36 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 8.67e-05 | 34 | 36 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.46e-05 | 35 | 36 | 3 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.03e-04 | 36 | 36 | 3 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.03e-04 | 36 | 36 | 3 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.12e-04 | 37 | 36 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.12e-04 | 37 | 36 | 3 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.31e-04 | 39 | 36 | 3 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.42e-04 | 40 | 36 | 3 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.53e-04 | 41 | 36 | 3 | MM15200 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.53e-04 | 41 | 36 | 3 | M29574 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.64e-04 | 42 | 36 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.76e-04 | 43 | 36 | 3 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.76e-04 | 43 | 36 | 3 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.89e-04 | 44 | 36 | 3 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.15e-04 | 46 | 36 | 3 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.30e-04 | 47 | 36 | 3 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.30e-04 | 47 | 36 | 3 | M27395 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.60e-04 | 49 | 36 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.76e-04 | 50 | 36 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.93e-04 | 51 | 36 | 3 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.28e-04 | 53 | 36 | 3 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.47e-04 | 54 | 36 | 3 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.66e-04 | 55 | 36 | 3 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.29e-04 | 58 | 36 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.29e-04 | 58 | 36 | 3 | MM14736 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 4.51e-04 | 59 | 36 | 3 | M27606 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 5.43e-04 | 149 | 36 | 4 | M4076 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.99e-04 | 65 | 36 | 3 | MM15147 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 6.05e-04 | 273 | 36 | 5 | M983 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 7.76e-04 | 71 | 36 | 3 | M27394 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 7.81e-04 | 612 | 36 | 7 | MM15547 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.41e-04 | 73 | 36 | 3 | MM14948 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 8.75e-04 | 74 | 36 | 3 | M48006 | |
| Pathway | WP_MRNA_PROCESSING | 8.94e-04 | 451 | 36 | 6 | MM15946 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 9.83e-04 | 77 | 36 | 3 | M27226 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.18e-03 | 82 | 36 | 3 | MM15394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.18e-03 | 82 | 36 | 3 | M27250 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.26e-03 | 84 | 36 | 3 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.26e-03 | 84 | 36 | 3 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.31e-03 | 85 | 36 | 3 | M1870 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.35e-03 | 86 | 36 | 3 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.64e-03 | 92 | 36 | 3 | MM14951 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.03e-03 | 99 | 36 | 3 | M27474 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.07e-03 | 724 | 36 | 7 | M16843 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 2.14e-03 | 27 | 36 | 2 | M29807 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.15e-03 | 101 | 36 | 3 | M27253 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.46e-03 | 106 | 36 | 3 | M27458 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 2.64e-03 | 30 | 36 | 2 | M47752 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 2.67e-03 | 109 | 36 | 3 | M39542 | |
| Pathway | REACTOME_HIV_INFECTION | 2.74e-03 | 231 | 36 | 4 | M12469 | |
| Pathway | REACTOME_TRNA_PROCESSING | 2.81e-03 | 111 | 36 | 3 | M27684 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.03e-03 | 114 | 36 | 3 | MM15361 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 3.18e-03 | 116 | 36 | 3 | M29806 | |
| Pathway | WP_MRNA_PROCESSING | 4.01e-03 | 126 | 36 | 3 | M39406 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.01e-03 | 126 | 36 | 3 | M45009 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 4.48e-03 | 131 | 36 | 3 | M5283 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 5.18e-03 | 138 | 36 | 3 | M29805 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.28e-03 | 139 | 36 | 3 | M715 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 5.60e-03 | 142 | 36 | 3 | M27660 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 7.39e-03 | 157 | 36 | 3 | M4669 | |
| Pathway | REACTOME_HCMV_INFECTION | 8.06e-03 | 162 | 36 | 3 | M29804 | |
| Pathway | REACTOME_SUMOYLATION | 9.04e-03 | 169 | 36 | 3 | MM14919 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.03e-02 | 177 | 36 | 3 | M27476 | |
| Pathway | REACTOME_SUMOYLATION | 1.22e-02 | 189 | 36 | 3 | M27214 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.23e-02 | 66 | 36 | 2 | MM17074 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.44e-02 | 201 | 36 | 3 | MM15411 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.49e-02 | 73 | 36 | 2 | MM15126 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.49e-02 | 73 | 36 | 2 | M39401 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.50e-02 | 204 | 36 | 3 | M45011 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.61e-02 | 76 | 36 | 2 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.61e-02 | 76 | 36 | 2 | M48037 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.62e-46 | 63 | 38 | 20 | 16831889 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 KRT15 KRT75 KRT17 KRT6C KRT77 | 5.76e-36 | 57 | 38 | 16 | 31862882 | |
| Pubmed | AAK1 KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 FUS KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 4.12e-35 | 266 | 38 | 21 | 19380743 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 KRT24 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 DHX9 | 1.53e-26 | 1153 | 38 | 24 | 29845934 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 KRT6C FXR2 HNRNPA1 KRT77 DHX9 | 1.18e-25 | 605 | 38 | 20 | 28977666 |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT77 | 1.85e-25 | 84 | 38 | 13 | 29563501 |
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 FUS ILF3 KRT15 KRT16 KRT17 KRT6C HNRNPA1 DHX9 | 1.47e-24 | 346 | 38 | 17 | 25324306 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 FUS ILF3 KRT16 KRT17 HNRNPA1 KRT27 KRT77 DHX9 | 9.43e-23 | 558 | 38 | 18 | 27591049 |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT77 | 1.24e-22 | 91 | 38 | 12 | 34445801 |
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 FUS KRT16 KRT6C HNRNPA1 | 2.50e-21 | 75 | 38 | 11 | 31527668 | |
| Pubmed | NUP98 KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 TAF15 KRT14 KRT76 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 TRO KRT77 | 3.90e-21 | 1442 | 38 | 22 | 35575683 | |
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT24 FUS KRT16 KRT75 KRT17 KRT6C KRT77 | 2.96e-20 | 488 | 38 | 16 | 31324722 | |
| Pubmed | 4.82e-20 | 60 | 38 | 10 | 31220272 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUP98 KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 FUS ILF3 KRT15 KRT16 KRT17 FXR2 HNRNPA1 KRT77 DHX9 | 2.26e-19 | 1257 | 38 | 20 | 36526897 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 FUS ILF3 KRT16 KRT17 FXR2 HNRNPA1 DHX9 | 2.26e-19 | 430 | 38 | 15 | 38172120 |
| Pubmed | 6.86e-19 | 45 | 38 | 9 | 30619335 | ||
| Pubmed | 8.52e-19 | 46 | 38 | 9 | 36147463 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | KRT1 KRT2 KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT6C HNRNPA1 KRT27 | 2.19e-18 | 135 | 38 | 11 | 29859926 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 CNOT11 KRT13 KRT14 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C FXR2 HNRNPA1 DHX9 | 2.26e-18 | 1415 | 38 | 20 | 28515276 |
| Pubmed | 4.09e-18 | 54 | 38 | 9 | 35474131 | ||
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 FUS ILF3 KRT16 KRT17 FXR2 | 4.61e-18 | 298 | 38 | 13 | 30737378 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | KRT1 KRT2 KRT9 KRT10 CNOT11 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 FXR2 HNRNPA1 TRO DHX9 | 5.46e-18 | 678 | 38 | 16 | 30209976 |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT14 FUS KRT16 KRT17 KRT77 | 6.36e-18 | 218 | 38 | 12 | 35831895 |
| Pubmed | 6.61e-18 | 15 | 38 | 7 | 10087197 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 KRT15 KRT16 KRT17 KRT6C KRT77 | 1.29e-17 | 564 | 38 | 15 | 21565611 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 KRT24 FUS KRT16 KRT17 FXR2 HNRNPA1 KRT77 DHX9 | 1.95e-17 | 580 | 38 | 15 | 35676659 |
| Pubmed | 2.17e-17 | 107 | 38 | 10 | 32989256 | ||
| Pubmed | KRT6A KRT6B KRT10 KRT13 NUP214 KRT14 KRT76 FUS KRT16 KRT75 KRT17 KRT77 | 1.56e-16 | 284 | 38 | 12 | 29459677 | |
| Pubmed | KRT1 KRT2 KRT6A KRT9 KRT10 KRT14 FUS ILF3 KRT16 KRT17 HNRNPA1 DHX9 | 1.70e-16 | 286 | 38 | 12 | 32041737 | |
| Pubmed | KRT1 KRT2 KRT6A KRT9 KRT10 KRT14 KRT24 FUS KRT16 KRT17 KRT77 DHX9 | 1.93e-16 | 289 | 38 | 12 | 37132043 | |
| Pubmed | 3.53e-16 | 24 | 38 | 7 | 30719818 | ||
| Pubmed | 3.53e-16 | 24 | 38 | 7 | 27507811 | ||
| Pubmed | 1.18e-15 | 5 | 38 | 5 | 20301457 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | KRT1 KRT2 KRT9 KRT10 KRT13 KRT14 KRT16 KRT75 KRT17 HNRNPA1 KRT77 | 1.25e-15 | 238 | 38 | 11 | 35864588 |
| Pubmed | KRT2 KRT6A KRT6B KRT10 TAF15 KRT14 FUS ILF3 KRT16 KRT77 DHX9 | 1.72e-15 | 245 | 38 | 11 | 35652658 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | KRT1 KRT4 KRT6A KRT6B KRT9 KRT10 KRT14 ILF3 KRT16 KRT17 HNRNPA1 | 1.88e-15 | 247 | 38 | 11 | 39238192 |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRT1 KRT2 KRT3 KRT4 KRT6B KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT6C KRT77 | 2.30e-15 | 630 | 38 | 14 | 36949045 |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 4.39e-15 | 113 | 38 | 9 | 34474245 | |
| Pubmed | 4.45e-15 | 65 | 38 | 8 | 29795372 | ||
| Pubmed | 6.57e-15 | 187 | 38 | 10 | 29777862 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 8.93e-15 | 16 | 38 | 6 | 12399393 | |
| Pubmed | 1.11e-14 | 197 | 38 | 10 | 23686814 | ||
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT15 KRT16 KRT17 | 1.54e-14 | 417 | 38 | 12 | 19199708 | |
| Pubmed | 3.02e-14 | 19 | 38 | 6 | 35173535 | ||
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 ILF3 KRT16 KRT17 KRT6C HNRNPA1 KRT77 DHX9 | 6.33e-14 | 803 | 38 | 14 | 36517590 | |
| Pubmed | 6.62e-14 | 8 | 38 | 5 | 19515043 | ||
| Pubmed | NUP98 KRT1 KRT2 KRT6B KRT9 KRT10 TAF15 KRT14 KRT16 KRT17 KRT6C HNRNPA1 DHX9 | 8.91e-14 | 641 | 38 | 13 | 36057605 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | KRT1 KRT2 KRT6A KRT9 KRT10 NUP214 KRT14 FUS KRT16 LZTS3 HNRNPA1 | 9.50e-14 | 353 | 38 | 11 | 27545878 |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.76e-13 | 169 | 38 | 9 | 23084401 | |
| Pubmed | NUP98 KRT1 KRT2 KRT6B KRT9 TAF15 KRT14 FUS ILF3 KRT17 FXR2 HNRNPA1 DHX9 | 3.31e-13 | 711 | 38 | 13 | 33022573 | |
| Pubmed | 3.39e-13 | 59 | 38 | 7 | 26371508 | ||
| Pubmed | 4.87e-13 | 62 | 38 | 7 | 26644517 | ||
| Pubmed | 5.24e-13 | 29 | 38 | 6 | 28049658 | ||
| Pubmed | 5.34e-13 | 191 | 38 | 9 | 33762435 | ||
| Pubmed | 5.44e-13 | 11 | 38 | 5 | 16085486 | ||
| Pubmed | 6.44e-13 | 421 | 38 | 11 | 34650049 | ||
| Pubmed | 8.83e-13 | 305 | 38 | 10 | 33194618 | ||
| Pubmed | KRT1 KRT2 KRT4 KRT6A KRT9 KRT10 KRT13 KRT14 KRT76 KRT15 KRT16 | 9.89e-13 | 438 | 38 | 11 | 21630459 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 22264670 | ||
| Pubmed | Mouse models in preclinical studies for pachyonychia congenita. | 1.21e-12 | 4 | 38 | 4 | 16250208 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 32179842 | ||
| Pubmed | Using transgenic models to study the pathogenesis of keratin-based inherited skin diseases. | 1.21e-12 | 4 | 38 | 4 | 10511477 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NUP98 KRT6A TAF15 NUP214 KRT14 FUS ILF3 NUP58 KRT16 KRT17 KRT6C HNRNPA1 KRT77 DHX9 | 1.69e-12 | 1024 | 38 | 14 | 24711643 |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 2.30e-12 | 336 | 38 | 10 | 31253590 | |
| Pubmed | 5.13e-12 | 16 | 38 | 5 | 17631878 | ||
| Pubmed | 6.05e-12 | 5 | 38 | 4 | 2458356 | ||
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 6.05e-12 | 5 | 38 | 4 | 12557214 | |
| Pubmed | 8.08e-12 | 162 | 38 | 8 | 15174051 | ||
| Pubmed | AAK1 SHANK1 KRT1 KRT2 KRT6A KRT6B KRT10 TAF15 KRT14 KRT76 ILF3 KRT16 LZTS3 HNRNPA1 DHX9 | 9.67e-12 | 1431 | 38 | 15 | 37142655 | |
| Pubmed | Dlx3 is a crucial regulator of hair follicle differentiation and cycling. | 1.00e-11 | 18 | 38 | 5 | 18684741 | |
| Pubmed | 1.00e-11 | 18 | 38 | 5 | 20335364 | ||
| Pubmed | 1.81e-11 | 6 | 38 | 4 | 15944823 | ||
| Pubmed | Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. | 1.81e-11 | 6 | 38 | 4 | 22135020 | |
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 2.38e-11 | 21 | 38 | 5 | 18824566 | |
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 2.38e-11 | 21 | 38 | 5 | 17373842 | |
| Pubmed | High proliferation and delamination during skin epidermal stratification. | 3.08e-11 | 22 | 38 | 5 | 34050161 | |
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 16818453 | ||
| Pubmed | 4.75e-11 | 202 | 38 | 8 | 24639526 | ||
| Pubmed | Barx2 functions through distinct corepressor classes to regulate hair follicle remodeling. | 4.96e-11 | 24 | 38 | 5 | 15728386 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | KRT1 KRT2 KRT3 KRT6A KRT9 KRT10 KRT13 KRT76 KRT24 KRT75 KRT6C KRT27 KRT77 | 5.46e-11 | 1070 | 38 | 13 | 23533145 |
| Pubmed | 7.16e-11 | 330 | 38 | 9 | 32529326 | ||
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 33294854 | ||
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.08e-10 | 224 | 38 | 8 | 28443643 | |
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 1.14e-10 | 28 | 38 | 5 | 32674056 | |
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 16093647 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 1.52e-10 | 9 | 38 | 4 | 16180309 | |
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 36049534 | ||
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 15737194 | ||
| Pubmed | Periderm Fate during Palatogenesis: TGF-β and Periderm Dedifferentiation. | 1.52e-10 | 9 | 38 | 4 | 36751050 | |
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 29450535 | ||
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 1.52e-10 | 9 | 38 | 4 | 19626033 | |
| Pubmed | microRNA-184 Induces a Commitment Switch to Epidermal Differentiation. | 1.52e-10 | 9 | 38 | 4 | 29198823 | |
| Pubmed | 1.81e-10 | 73 | 38 | 6 | 35973989 | ||
| Pubmed | 1.97e-10 | 31 | 38 | 5 | 20930145 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 1.97e-10 | 31 | 38 | 5 | 37115925 | |
| Pubmed | 2.53e-10 | 10 | 38 | 4 | 24940650 | ||
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 2.53e-10 | 10 | 38 | 4 | 10571739 | |
| Pubmed | Essential role for Sonic hedgehog during hair follicle morphogenesis. | 2.53e-10 | 10 | 38 | 4 | 9882493 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 2.99e-10 | 152 | 38 | 7 | 28192407 | |
| Pubmed | Eyelid closure in embryogenesis is required for ocular adnexa development. | 3.97e-10 | 11 | 38 | 4 | 25377219 | |
| Interaction | RNF208 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 KRT15 KRT75 KRT17 KRT6C KRT77 | 5.09e-30 | 75 | 38 | 16 | int:RNF208 |
| Interaction | KRT7 interactions | KRT1 KRT2 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.60e-29 | 80 | 38 | 16 | int:KRT7 |
| Interaction | KRT5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 | 5.36e-29 | 193 | 38 | 19 | int:KRT5 |
| Interaction | PRPH interactions | AAK1 KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT14 KRT76 KRT24 ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.60e-28 | 204 | 38 | 19 | int:PRPH |
| Interaction | KRT84 interactions | KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 3.02e-28 | 49 | 38 | 14 | int:KRT84 |
| Interaction | KRT75 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 1.75e-27 | 181 | 38 | 18 | int:KRT75 |
| Interaction | KRT6A interactions | KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 | 2.06e-26 | 160 | 38 | 17 | int:KRT6A |
| Interaction | DES interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.79e-24 | 158 | 38 | 16 | int:DES |
| Interaction | HEXIM1 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 KRT24 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 DHX9 | 2.20e-23 | 913 | 38 | 24 | int:HEXIM1 |
| Interaction | KRT17 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 ILF3 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 | 5.91e-23 | 252 | 38 | 17 | int:KRT17 |
| Interaction | KRT20 interactions | KRT2 KRT3 KRT6A KRT6B KRT13 KRT76 KRT24 KRT15 KRT75 KRT6C FXR2 KRT27 | 7.28e-22 | 63 | 38 | 12 | int:KRT20 |
| Interaction | KRT8 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT27 KRT77 | 2.11e-20 | 441 | 38 | 18 | int:KRT8 |
| Interaction | KRT19 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT12 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 2.38e-20 | 282 | 38 | 16 | int:KRT19 |
| Interaction | KRT25 interactions | 2.77e-20 | 35 | 38 | 10 | int:KRT25 | |
| Interaction | CRK interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT14 KRT76 KRT24 KRT15 KRT16 KRT17 KRT77 DHX9 | 4.30e-20 | 370 | 38 | 17 | int:CRK |
| Interaction | KRT2 interactions | KRT1 KRT2 KRT6A KRT10 KRT12 KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 HNRNPA1 KRT27 KRT77 | 8.31e-20 | 236 | 38 | 15 | int:KRT2 |
| Interaction | KRT6B interactions | KRT6A KRT6B KRT10 KRT12 KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 HNRNPA1 KRT27 | 1.05e-19 | 132 | 38 | 13 | int:KRT6B |
| Interaction | CUL2 interactions | KRT1 KRT2 KRT6A KRT9 KRT10 KRT13 TAF15 NUP214 KRT14 KRT76 KRT24 FUS ILF3 KRT16 KRT75 KRT6C HNRNPA1 KRT27 DHX9 | 1.19e-19 | 591 | 38 | 19 | int:CUL2 |
| Interaction | MEPCE interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 DHX9 | 1.91e-19 | 859 | 38 | 21 | int:MEPCE |
| Interaction | KRT18 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT12 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C FXR2 KRT77 | 3.54e-19 | 419 | 38 | 17 | int:KRT18 |
| Interaction | KRT16 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT10 KRT76 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT77 | 3.59e-19 | 197 | 38 | 14 | int:KRT16 |
| Interaction | KRT6C interactions | KRT6A KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 | 1.14e-18 | 76 | 38 | 11 | int:KRT6C |
| Interaction | KRT28 interactions | 1.50e-18 | 30 | 38 | 9 | int:KRT28 | |
| Interaction | LARP7 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 KRT76 FUS ILF3 KRT15 KRT16 KRT75 KRT17 KRT6C HNRNPA1 KRT27 KRT77 DHX9 | 1.66e-18 | 1113 | 38 | 22 | int:LARP7 |
| Interaction | KRT76 interactions | KRT6A KRT10 KRT12 KRT13 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT27 | 3.67e-18 | 84 | 38 | 11 | int:KRT76 |
| Interaction | ZUP1 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT77 | 4.22e-18 | 174 | 38 | 13 | int:ZUP1 |
| Interaction | KRT1 interactions | KRT1 KRT2 KRT9 KRT10 KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 HNRNPA1 KRT27 KRT77 | 5.26e-18 | 238 | 38 | 14 | int:KRT1 |
| Interaction | KRT79 interactions | KRT6A KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 HNRNPA1 KRT27 | 9.19e-18 | 59 | 38 | 10 | int:KRT79 |
| Interaction | CHD3 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 FUS ILF3 KRT16 KRT17 KRT6C FXR2 HNRNPA1 KRT77 DHX9 | 1.21e-17 | 757 | 38 | 19 | int:CHD3 |
| Interaction | KRT14 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT14 KRT76 KRT75 KRT17 KRT6C HNRNPA1 KRT77 | 1.55e-17 | 192 | 38 | 13 | int:KRT14 |
| Interaction | KRT77 interactions | KRT1 KRT2 KRT6A KRT10 KRT14 KRT15 KRT16 KRT75 KRT17 KRT27 KRT77 | 1.72e-17 | 96 | 38 | 11 | int:KRT77 |
| Interaction | CHD4 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B TEAD2 KRT9 KRT10 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 KRT6C FXR2 HNRNPA1 KRT77 DHX9 | 2.83e-17 | 938 | 38 | 20 | int:CHD4 |
| Interaction | KRT27 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT76 NUP58 KRT75 KRT17 KRT6C KRT27 KRT77 | 3.03e-17 | 202 | 38 | 13 | int:KRT27 |
| Interaction | CUL5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT24 FUS ILF3 KRT75 HNRNPA1 KRT77 DHX9 | 5.70e-17 | 567 | 38 | 17 | int:CUL5 |
| Interaction | KRT35 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT76 KRT75 KRT6C KRT27 KRT77 | 9.05e-17 | 111 | 38 | 11 | int:KRT35 |
| Interaction | KRT36 interactions | 1.03e-16 | 74 | 38 | 10 | int:KRT36 | |
| Interaction | KRT13 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT13 KRT76 KRT75 KRT17 KRT6C | 1.49e-16 | 116 | 38 | 11 | int:KRT13 |
| Interaction | CYLD interactions | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 NUP214 KRT14 FUS ILF3 KRT16 KRT17 HNRNPA1 KRT27 KRT77 DHX9 | 1.51e-16 | 868 | 38 | 19 | int:CYLD |
| Interaction | NEDD8 interactions | KRT1 KRT2 KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 KRT24 FUS ILF3 KRT16 KRT75 HNRNPA1 DHX9 | 1.77e-16 | 393 | 38 | 15 | int:NEDD8 |
| Interaction | KRT15 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT76 KRT15 KRT75 KRT6C HNRNPA1 KRT77 | 3.44e-16 | 178 | 38 | 12 | int:KRT15 |
| Interaction | DDX3X interactions | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 FXR2 HNRNPA1 KRT77 | 5.66e-16 | 651 | 38 | 17 | int:DDX3X |
| Interaction | COPS5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 KRT24 FUS ILF3 KRT16 KRT75 KRT17 KRT6C HNRNPA1 DHX9 | 6.33e-16 | 1102 | 38 | 20 | int:COPS5 |
| Interaction | KRT3 interactions | 6.36e-16 | 88 | 38 | 10 | int:KRT3 | |
| Interaction | KRT33B interactions | 1.13e-15 | 93 | 38 | 10 | int:KRT33B | |
| Interaction | KRT72 interactions | 1.27e-15 | 59 | 38 | 9 | int:KRT72 | |
| Interaction | KRT26 interactions | 1.65e-15 | 35 | 38 | 8 | int:KRT26 | |
| Interaction | DDX39B interactions | KRT1 KRT2 KRT4 KRT6A KRT6B KRT9 KRT10 KRT14 FUS ILF3 KRT16 KRT17 KRT6C HNRNPA1 KRT77 DHX9 | 1.70e-15 | 570 | 38 | 16 | int:DDX39B |
| Interaction | EFNA1 interactions | 3.26e-15 | 103 | 38 | 10 | int:EFNA1 | |
| Interaction | PHTF1 interactions | 3.59e-15 | 20 | 38 | 7 | int:PHTF1 | |
| Interaction | EPS15 interactions | AGFG2 KRT1 KRT2 KRT3 KRT4 KRT6A KRT9 KRT10 KRT14 KRT16 KRT75 KRT17 | 4.47e-15 | 220 | 38 | 12 | int:EPS15 |
| Interaction | KRT12 interactions | 1.60e-14 | 24 | 38 | 7 | int:KRT12 | |
| Interaction | VIM interactions | AAK1 KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT12 KRT14 KRT76 KRT15 KRT16 KRT75 KRT17 KRT6C FXR2 KRT77 | 1.82e-14 | 804 | 38 | 17 | int:VIM |
| Interaction | RC3H2 interactions | KRT1 KRT2 KRT9 KRT10 CNOT11 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 FXR2 HNRNPA1 TRO DHX9 | 1.96e-14 | 667 | 38 | 16 | int:RC3H2 |
| Interaction | KRT10 interactions | KRT1 KRT2 KRT6A KRT6B KRT10 KRT76 KRT16 KRT75 KRT17 HNRNPA1 KRT77 | 3.16e-14 | 187 | 38 | 11 | int:KRT10 |
| Interaction | RPS6KB2 interactions | KRT1 KRT2 KRT6A KRT9 KRT10 KRT13 TAF15 KRT14 FUS KRT16 HNRNPA1 DHX9 | 3.47e-14 | 261 | 38 | 12 | int:RPS6KB2 |
| Interaction | FBP1 interactions | KRT1 KRT2 KRT6A KRT9 KRT10 KRT14 FUS ILF3 KRT16 KRT17 FXR2 HNRNPA1 DHX9 | 3.56e-14 | 348 | 38 | 13 | int:FBP1 |
| Interaction | DCUN1D1 interactions | KRT1 KRT2 KRT9 KRT10 TAF15 KRT24 FUS ILF3 KRT75 HNRNPA1 KRT77 DHX9 | 6.48e-14 | 275 | 38 | 12 | int:DCUN1D1 |
| Interaction | KRT24 interactions | 7.10e-14 | 54 | 38 | 8 | int:KRT24 | |
| Interaction | CUL1 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT24 FUS ILF3 KRT16 KRT75 KRT6C HNRNPA1 DHX9 | 7.38e-14 | 876 | 38 | 17 | int:CUL1 |
| Interaction | CUL4B interactions | KRT1 KRT2 KRT9 KRT10 KRT13 TAF15 NUP214 KRT14 KRT76 KRT24 FUS ILF3 KRT16 KRT75 HNRNPA1 DHX9 | 7.57e-14 | 728 | 38 | 16 | int:CUL4B |
| Interaction | ALB interactions | KRT1 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 FUS KRT16 KRT17 HNRNPA1 SRGN | 1.58e-13 | 391 | 38 | 13 | int:ALB |
| Interaction | UBASH3B interactions | 2.42e-13 | 157 | 38 | 10 | int:UBASH3B | |
| Interaction | PIK3R2 interactions | 3.09e-13 | 230 | 38 | 11 | int:PIK3R2 | |
| Interaction | EFNA3 interactions | 3.72e-13 | 108 | 38 | 9 | int:EFNA3 | |
| Interaction | RNF8 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 FUS KRT16 KRT17 KRT77 | 4.05e-13 | 421 | 38 | 13 | int:RNF8 |
| Interaction | AP2M1 interactions | AAK1 KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT14 KRT16 KRT17 FXR2 KRT77 | 5.29e-13 | 430 | 38 | 13 | int:AP2M1 |
| Interaction | MINDY4 interactions | 8.95e-13 | 73 | 38 | 8 | int:MINDY4 | |
| Interaction | KRT71 interactions | 1.45e-12 | 43 | 38 | 7 | int:KRT71 | |
| Interaction | SHC1 interactions | KRT1 KRT2 KRT3 KRT4 KRT6A KRT9 KRT10 KRT13 KRT14 KRT16 KRT17 KRT77 | 1.67e-12 | 362 | 38 | 12 | int:SHC1 |
| Interaction | CAND1 interactions | KRT1 KRT2 KRT6B KRT9 KRT10 KRT13 TAF15 KRT14 KRT76 FUS ILF3 KRT16 KRT75 FXR2 HNRNPA1 DHX9 | 1.75e-12 | 894 | 38 | 16 | int:CAND1 |
| Interaction | WTAP interactions | 2.02e-12 | 194 | 38 | 10 | int:WTAP | |
| Interaction | IQCB1 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 KRT15 KRT16 KRT17 KRT6C KRT77 | 2.16e-12 | 370 | 38 | 12 | int:IQCB1 |
| Interaction | TIMP2 interactions | KRT1 KRT4 KRT6A KRT6B KRT9 KRT10 KRT14 ILF3 KRT16 KRT17 HNRNPA1 | 2.35e-12 | 277 | 38 | 11 | int:TIMP2 |
| Interaction | PHGDH interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 FUS ILF3 KRT16 KRT17 HNRNPA1 | 3.45e-12 | 385 | 38 | 12 | int:PHGDH |
| Interaction | MKS1 interactions | 3.74e-12 | 139 | 38 | 9 | int:MKS1 | |
| Interaction | KRT78 interactions | 3.82e-12 | 87 | 38 | 8 | int:KRT78 | |
| Interaction | HNRNPA1 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 TAF15 KRT14 FUS ILF3 KRT15 KRT16 KRT17 KRT6C HNRNPA1 DHX9 | 4.06e-12 | 945 | 38 | 16 | int:HNRNPA1 |
| Interaction | RLIM interactions | KRT1 KRT2 KRT6A KRT9 KRT10 KRT14 KRT24 FUS KRT16 KRT17 KRT77 DHX9 | 4.26e-12 | 392 | 38 | 12 | int:RLIM |
| Interaction | EIF3F interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 FUS KRT16 KRT6C HNRNPA1 | 4.82e-12 | 296 | 38 | 11 | int:EIF3F |
| Interaction | INPPL1 interactions | 5.39e-12 | 214 | 38 | 10 | int:INPPL1 | |
| Interaction | KRT37 interactions | 1.20e-11 | 100 | 38 | 8 | int:KRT37 | |
| Interaction | METTL14 interactions | KRT1 KRT2 KRT4 KRT6B KRT9 KRT10 KRT14 FUS ILF3 KRT16 HNRNPA1 KRT77 DHX9 | 1.41e-11 | 558 | 38 | 13 | int:METTL14 |
| Interaction | NPHP4 interactions | 1.42e-11 | 236 | 38 | 10 | int:NPHP4 | |
| Interaction | EFNA4 interactions | 1.61e-11 | 239 | 38 | 10 | int:EFNA4 | |
| Interaction | EFTUD2 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 CNOT11 KRT13 TAF15 KRT14 FUS ILF3 KRT16 KRT17 KRT6C FXR2 HNRNPA1 DHX9 | 2.00e-11 | 1449 | 38 | 18 | int:EFTUD2 |
| Interaction | KRT4 interactions | 2.15e-11 | 62 | 38 | 7 | int:KRT4 | |
| Interaction | KRT38 interactions | 2.57e-11 | 172 | 38 | 9 | int:KRT38 | |
| Interaction | KIFC3 interactions | 2.72e-11 | 252 | 38 | 10 | int:KIFC3 | |
| Interaction | ACE2 interactions | NUP98 SHANK1 KRT1 KRT2 KRT6B KRT9 KRT10 TAF15 KRT14 FUS ILF3 KRT16 KRT17 KRT6C HNRNPA1 DHX9 | 4.31e-11 | 1106 | 38 | 16 | int:ACE2 |
| Interaction | HDAC6 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 KRT24 FUS KRT16 KRT17 FXR2 HNRNPA1 KRT77 DHX9 | 4.61e-11 | 929 | 38 | 15 | int:HDAC6 |
| Interaction | PRPF8 interactions | KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT14 FUS ILF3 KRT15 KRT16 KRT75 HNRNPA1 DHX9 | 5.74e-11 | 776 | 38 | 14 | int:PRPF8 |
| Interaction | KRT74 interactions | 6.62e-11 | 37 | 38 | 6 | int:KRT74 | |
| Interaction | C1orf216 interactions | 7.03e-11 | 73 | 38 | 7 | int:C1orf216 | |
| Interaction | TEDC2 interactions | 1.29e-10 | 206 | 38 | 9 | int:TEDC2 | |
| Interaction | FGD5 interactions | 1.35e-10 | 207 | 38 | 9 | int:FGD5 | |
| Interaction | CIBAR1 interactions | 1.53e-10 | 137 | 38 | 8 | int:CIBAR1 | |
| Interaction | AHI1 interactions | 1.77e-10 | 83 | 38 | 7 | int:AHI1 | |
| Interaction | ARIH2 interactions | 2.35e-10 | 314 | 38 | 10 | int:ARIH2 | |
| Interaction | OBSL1 interactions | NUP98 KRT6A KRT6B TAF15 NUP214 KRT14 FUS ILF3 NUP58 KRT16 KRT17 FXR2 HNRNPA1 DHX9 | 4.15e-10 | 902 | 38 | 14 | int:OBSL1 |
| Interaction | TRIM31 interactions | 4.68e-10 | 454 | 38 | 11 | int:TRIM31 | |
| Cytoband | 12q13.13 | 2.70e-18 | 67 | 38 | 9 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT76 KRT75 KRT6C HNRNPA1 KRT77 | 3.44e-14 | 423 | 38 | 11 | chr12q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 4.48e-12 | 473 | 38 | 10 | chr17q21 | |
| Cytoband | 17q21.2 | 3.44e-09 | 70 | 38 | 5 | 17q21.2 | |
| Cytoband | 19q13.3 | 2.12e-03 | 82 | 38 | 2 | 19q13.3 | |
| GeneFamily | Keratins, type II | 1.48e-21 | 27 | 35 | 10 | 609 | |
| GeneFamily | Keratins, type I | 2.30e-21 | 28 | 35 | 10 | 608 | |
| GeneFamily | Nucleoporins | 3.17e-05 | 32 | 35 | 3 | 1051 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 7.47e-04 | 21 | 35 | 2 | 89 | |
| GeneFamily | RNA binding motif containing | 8.00e-03 | 213 | 35 | 3 | 725 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 4.86e-14 | 173 | 38 | 10 | M650 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 5.44e-14 | 67 | 38 | 8 | M40299 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.56e-13 | 204 | 38 | 10 | MM966 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 2.62e-10 | 8 | 38 | 4 | M19218 | |
| Coexpression | DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS | 6.60e-10 | 129 | 38 | 7 | M40122 | |
| Coexpression | GU_PDEF_TARGETS_DN | 3.09e-09 | 40 | 38 | 5 | M10480 | |
| Coexpression | JAEGER_METASTASIS_DN | 3.18e-09 | 260 | 38 | 8 | M10702 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 5.07e-09 | 15 | 38 | 4 | M13308 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 5.12e-08 | 69 | 38 | 5 | M2533 | |
| Coexpression | LEI_MYB_TARGETS | 3.68e-07 | 323 | 38 | 7 | M863 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 4.63e-07 | 204 | 38 | 6 | MM17090 | |
| Coexpression | DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS | 4.90e-07 | 206 | 38 | 6 | M40237 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.31e-06 | 56 | 38 | 4 | MM3852 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 1.76e-06 | 140 | 38 | 5 | M40004 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 1.89e-06 | 142 | 38 | 5 | M2893 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.31e-06 | 615 | 38 | 8 | M8673 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 2.76e-06 | 630 | 38 | 8 | MM1038 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 3.15e-06 | 20 | 38 | 3 | M17175 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 3.67e-06 | 21 | 38 | 3 | M16756 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 3.84e-06 | 659 | 38 | 8 | MM1040 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | 3.97e-06 | 662 | 38 | 8 | M8124 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 4.57e-06 | 170 | 38 | 5 | M6822 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 4.64e-06 | 473 | 38 | 7 | M4306 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN | 9.57e-06 | 92 | 38 | 4 | M3672 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP | 1.01e-05 | 200 | 38 | 5 | M8201 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 1.08e-05 | 352 | 38 | 6 | MM3788 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.16e-05 | 206 | 38 | 5 | M14134 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_B_CELL_AGEING | 1.33e-05 | 100 | 38 | 4 | MM3697 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.54e-05 | 569 | 38 | 7 | M12701 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | 1.88e-05 | 587 | 38 | 7 | M17572 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN | 2.11e-05 | 37 | 38 | 3 | M16944 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN | 2.16e-05 | 113 | 38 | 4 | M9524 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.41e-05 | 610 | 38 | 7 | M3854 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 3.61e-05 | 650 | 38 | 7 | MM1042 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON | 3.97e-05 | 132 | 38 | 4 | M3434 | |
| Coexpression | KRAS.50_UP.V1_DN | 4.36e-05 | 47 | 38 | 3 | M2876 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | 4.68e-05 | 457 | 38 | 6 | M14507 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_UP | 4.86e-05 | 139 | 38 | 4 | M2534 | |
| Coexpression | CROMER_TUMORIGENESIS_DN | 4.95e-05 | 49 | 38 | 3 | M16948 | |
| Coexpression | KRAS.600_UP.V1_DN | 4.96e-05 | 279 | 38 | 5 | M2880 | |
| Coexpression | KRAS.300_UP.V1_DN | 5.00e-05 | 140 | 38 | 4 | M2874 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 5.22e-05 | 689 | 38 | 7 | MM1041 | |
| Coexpression | HUPER_BREAST_BASAL_VS_LUMINAL_UP | 6.26e-05 | 53 | 38 | 3 | M13422 | |
| Coexpression | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM | 8.60e-05 | 161 | 38 | 4 | M5075 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_DN | 8.81e-05 | 162 | 38 | 4 | M5654 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | 1.00e-04 | 324 | 38 | 5 | M2700 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN | 1.19e-04 | 175 | 38 | 4 | M6750 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 1.44e-04 | 70 | 38 | 3 | M40002 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.58e-04 | 13 | 38 | 2 | MM743 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.63e-04 | 190 | 38 | 4 | MM3832 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 1.66e-04 | 191 | 38 | 4 | M2647 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 1.83e-04 | 843 | 38 | 7 | M2356 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP | 1.83e-04 | 196 | 38 | 4 | M5252 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN | 1.84e-04 | 14 | 38 | 2 | M34015 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.87e-04 | 197 | 38 | 4 | M5150 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN | 1.98e-04 | 200 | 38 | 4 | M4039 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 1.98e-04 | 200 | 38 | 4 | M8212 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 1.98e-04 | 200 | 38 | 4 | M8203 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.98e-04 | 200 | 38 | 4 | M5956 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 2.22e-04 | 384 | 38 | 5 | M12527 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 2.30e-04 | 82 | 38 | 3 | MM3777 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 2.42e-04 | 16 | 38 | 2 | M1122 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 2.54e-04 | 623 | 38 | 6 | M15896 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | 2.57e-04 | 891 | 38 | 7 | M41654 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS | 3.45e-04 | 19 | 38 | 2 | M39272 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 3.45e-04 | 19 | 38 | 2 | M1126 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 3.66e-04 | 96 | 38 | 3 | M5549 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | 3.72e-04 | 669 | 38 | 6 | M18635 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 3.81e-04 | 432 | 38 | 5 | M41149 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 3.83e-04 | 20 | 38 | 2 | MM491 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 4.36e-04 | 445 | 38 | 5 | M3645 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 4.37e-04 | 102 | 38 | 3 | M14455 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 4.38e-04 | 690 | 38 | 6 | M12224 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 4.52e-04 | 694 | 38 | 6 | MM1039 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_DN | 5.08e-04 | 23 | 38 | 2 | M2176 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 5.08e-04 | 23 | 38 | 2 | MM492 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 5.81e-04 | 474 | 38 | 5 | M40991 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL | 5.83e-04 | 266 | 38 | 4 | M45715 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.09e-04 | 479 | 38 | 5 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.33e-04 | 483 | 38 | 5 | MM1082 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 6.38e-04 | 741 | 38 | 6 | MM1037 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 6.94e-04 | 493 | 38 | 5 | M19391 | |
| Coexpression | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP | 7.19e-04 | 121 | 38 | 3 | M8475 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 7.45e-04 | 284 | 38 | 4 | M2885 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN | 7.95e-04 | 289 | 38 | 4 | M38973 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 8.07e-04 | 775 | 38 | 6 | M45713 | |
| Coexpression | LIANG_SILENCED_BY_METHYLATION_UP | 1.05e-03 | 33 | 38 | 2 | M14553 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 1.12e-03 | 141 | 38 | 3 | M2901 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 1.12e-03 | 141 | 38 | 3 | M2898 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 1.17e-03 | 143 | 38 | 3 | MM3673 | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP | 1.19e-03 | 144 | 38 | 3 | M34020 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.20e-03 | 323 | 38 | 4 | M9150 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 1.21e-03 | 145 | 38 | 3 | M11513 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 1.31e-03 | 149 | 38 | 3 | M45703 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP | 1.42e-03 | 153 | 38 | 3 | M438 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 1.42e-03 | 338 | 38 | 4 | M17094 | |
| Coexpression | AMIT_SERUM_RESPONSE_480_MCF10A | 1.47e-03 | 39 | 38 | 2 | M8202 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 1.55e-03 | 158 | 38 | 3 | MM3851 | |
| Coexpression | MA_RAT_AGING_DN | 1.64e-03 | 161 | 38 | 3 | M46419 | |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 1.76e-03 | 165 | 38 | 3 | M43617 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 7.29e-14 | 98 | 37 | 9 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | KRT1 KRT4 KRT6A KRT6B KRT10 KRT13 KRT14 KRT15 KRT16 KRT17 KRT27 | 1.02e-10 | 427 | 37 | 11 | Facebase_ST1_Univ_500 |
| CoexpressionAtlas | esophagus | 3.16e-10 | 247 | 37 | 9 | esophagus | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 7.70e-10 | 59 | 37 | 6 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.64e-09 | 123 | 37 | 7 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.52e-09 | 325 | 37 | 9 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 1.71e-08 | 98 | 37 | 6 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 5.87e-08 | 206 | 37 | 7 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 9.61e-08 | 25 | 37 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | 1.34e-07 | 496 | 37 | 9 | PCBC_ctl_BronchioEpithel_500 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 2.49e-07 | 79 | 37 | 5 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 3.39e-07 | 84 | 37 | 5 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | BM Top 100 - esophagus | 3.81e-07 | 86 | 37 | 5 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 4.04e-07 | 87 | 37 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | skin | 9.51e-07 | 456 | 37 | 8 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_4 | 1.80e-06 | 215 | 37 | 6 | Facebase_ST1_Univ_500_4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 4.71e-06 | 981 | 37 | 10 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 5.11e-06 | 990 | 37 | 10 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 5.13e-06 | 401 | 37 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| CoexpressionAtlas | BM Top 100 - trachea | 7.37e-06 | 72 | 37 | 4 | BM Top 100 - trachea | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 7.62e-06 | 426 | 37 | 7 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - vagina | 9.15e-06 | 76 | 37 | 4 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 1.01e-05 | 78 | 37 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 1.04e-05 | 168 | 37 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 1.10e-05 | 451 | 37 | 7 | GSM538280_500 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 1.24e-05 | 82 | 37 | 4 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | BM Top 100 - oral mucosa | 1.30e-05 | 83 | 37 | 4 | BM Top 100 - oral mucosa | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 1.36e-05 | 84 | 37 | 4 | Facebase_ST1_Univ_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_500 | 1.96e-05 | 493 | 37 | 7 | PCBC_ctl_SmallAirwayEpithel_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 3.24e-05 | 969 | 37 | 9 | PCBC_MESO-5_blastocyst_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 4.33e-05 | 769 | 37 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_500 | 5.37e-05 | 119 | 37 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 5.73e-05 | 800 | 37 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 6.63e-05 | 406 | 37 | 6 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 6.72e-05 | 407 | 37 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_100 | 8.22e-05 | 8 | 37 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | 1.32e-04 | 150 | 37 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 1.57e-04 | 157 | 37 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_100 | 1.61e-04 | 11 | 37 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_500 | 1.63e-04 | 61 | 37 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200 | 1.97e-04 | 65 | 37 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 1.98e-04 | 496 | 37 | 6 | Arv_EB-LF_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 2.45e-04 | 987 | 37 | 8 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | BM Top 100 - tonsil | 2.46e-04 | 70 | 37 | 3 | BM Top 100 - tonsil | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 3.02e-04 | 75 | 37 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 3.14e-04 | 76 | 37 | 3 | BM Top 100 - bronchus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 3.39e-04 | 78 | 37 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_200 | 3.49e-04 | 16 | 37 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k4 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 3.65e-04 | 80 | 37 | 3 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | BM Top 100 - vulva | 3.92e-04 | 82 | 37 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 4.18e-04 | 805 | 37 | 7 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 4.21e-04 | 806 | 37 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.81e-04 | 379 | 37 | 5 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_100 | 4.96e-04 | 19 | 37 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 5.10e-04 | 384 | 37 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 5.32e-04 | 91 | 37 | 3 | GSM538280_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 5.47e-04 | 390 | 37 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.50e-04 | 92 | 37 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#3_top-relative-expression-ranked_100 | 1.01e-03 | 27 | 37 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.13e-03 | 118 | 37 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_100 | 1.16e-03 | 29 | 37 | 2 | gudmap_developingLowerUrinaryTract_adult_ureter_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.19e-03 | 120 | 37 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | breast | 1.31e-03 | 124 | 37 | 3 | breast | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.32e-03 | 276 | 37 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | 1.34e-03 | 981 | 37 | 7 | Arv_EB-LF_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 1.39e-03 | 987 | 37 | 7 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_200 | 1.51e-03 | 33 | 37 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_200 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | 1.53e-03 | 131 | 37 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.99e-03 | 309 | 37 | 4 | ratio_EB_vs_SC_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_200 | 2.10e-03 | 39 | 37 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_200 | 2.10e-03 | 39 | 37 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_200 | 2.32e-03 | 41 | 37 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 2.33e-03 | 795 | 37 | 6 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 2.52e-03 | 156 | 37 | 3 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.75e-03 | 161 | 37 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.78e-03 | 339 | 37 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 2.95e-03 | 165 | 37 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 3.04e-03 | 47 | 37 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k1 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | KRT1 KRT3 KRT4 KRT6A KRT6B KRT13 KRT14 KRT76 KRT16 KRT17 KRT6C | 8.77e-18 | 196 | 38 | 11 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | KRT1 KRT3 KRT4 KRT6A KRT6B KRT13 KRT14 KRT76 KRT16 KRT17 KRT6C | 9.28e-18 | 197 | 38 | 11 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.74e-16 | 197 | 38 | 10 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 2.09e-14 | 172 | 38 | 9 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.18e-14 | 190 | 38 | 9 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.18e-14 | 190 | 38 | 9 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.18e-14 | 190 | 38 | 9 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-14 | 191 | 38 | 9 | cd4e2e883c4955fb2d875e41bb6ebc680994dc8c | |
| ToppCell | facs-Trachea-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.69e-14 | 192 | 38 | 9 | c5823c5d4c58a4e9121a4b7d7256481d6d9e9b7f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-14 | 197 | 38 | 9 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-14 | 197 | 38 | 9 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.19e-14 | 197 | 38 | 9 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-14 | 197 | 38 | 9 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.19e-14 | 197 | 38 | 9 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-14 | 198 | 38 | 9 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-12 | 161 | 38 | 8 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 1.80e-12 | 173 | 38 | 8 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.88e-12 | 174 | 38 | 8 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-12 | 174 | 38 | 8 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-12 | 175 | 38 | 8 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.16e-12 | 177 | 38 | 8 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-12 | 185 | 38 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.37e-12 | 187 | 38 | 8 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-Trachea-nan-18m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-12 | 187 | 38 | 8 | 8882a638af7165b2910ba8e932d55475d7bfb003 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.67e-12 | 189 | 38 | 8 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.67e-12 | 189 | 38 | 8 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-12 | 192 | 38 | 8 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-12 | 192 | 38 | 8 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.52e-12 | 194 | 38 | 8 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | droplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-12 | 195 | 38 | 8 | e460b09ae354b579ce552acebdaa5877a6e62343 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-12 | 195 | 38 | 8 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 4.91e-12 | 196 | 38 | 8 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.12e-12 | 197 | 38 | 8 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-12 | 197 | 38 | 8 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-12 | 198 | 38 | 8 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.33e-12 | 198 | 38 | 8 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-12 | 198 | 38 | 8 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-12 | 198 | 38 | 8 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-12 | 198 | 38 | 8 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.55e-12 | 199 | 38 | 8 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.78e-12 | 200 | 38 | 8 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.78e-12 | 200 | 38 | 8 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.78e-12 | 200 | 38 | 8 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.78e-12 | 200 | 38 | 8 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.78e-12 | 200 | 38 | 8 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | distal-Epithelial-Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.78e-12 | 200 | 38 | 8 | 5c14f0c09bb8b3daf6d649032e888a7880c52b73 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.26e-11 | 163 | 38 | 7 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-10 | 168 | 38 | 7 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-10 | 172 | 38 | 7 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-10 | 173 | 38 | 7 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-10 | 175 | 38 | 7 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-10 | 175 | 38 | 7 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | facs-Trachea-18m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-10 | 177 | 38 | 7 | 68c9a8a82c956cbfdf03b44984c97f978aaaf80f | |
| ToppCell | facs-Trachea-nan-18m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-10 | 177 | 38 | 7 | fc30276903bcb1e95ae76f6cee3d17408158941a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-10 | 181 | 38 | 7 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-10 | 181 | 38 | 7 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.93e-10 | 184 | 38 | 7 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-10 | 186 | 38 | 7 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-10 | 188 | 38 | 7 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-10 | 192 | 38 | 7 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-10 | 193 | 38 | 7 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-10 | 193 | 38 | 7 | 77bc4353a1e9eae32bc6beb333577ba0294a10fc | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-10 | 193 | 38 | 7 | b9b431c18c81c616069a546cded4753563a1e701 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.70e-10 | 193 | 38 | 7 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-10 | 193 | 38 | 7 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.80e-10 | 194 | 38 | 7 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte-new-cluster|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-10 | 194 | 38 | 7 | b847c5b4e8914b1c306bfff3d7119c32063784a8 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-10 | 194 | 38 | 7 | bd94d30584128628b34ed8c3857ce103586cfe2e | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.12e-10 | 197 | 38 | 7 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-10 | 197 | 38 | 7 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-10 | 197 | 38 | 7 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-10 | 197 | 38 | 7 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.23e-10 | 198 | 38 | 7 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-10 | 198 | 38 | 7 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-10 | 198 | 38 | 7 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.35e-10 | 199 | 38 | 7 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.35e-10 | 199 | 38 | 7 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.47e-10 | 200 | 38 | 7 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-10 | 200 | 38 | 7 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.13e-09 | 157 | 38 | 6 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.29e-09 | 158 | 38 | 6 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-09 | 160 | 38 | 6 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-09 | 160 | 38 | 6 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | facs-Lung-24m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-09 | 162 | 38 | 6 | 4e418bea07e35038b32a78a1e6632b6ec1208cdc | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-09 | 162 | 38 | 6 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-09 | 162 | 38 | 6 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-09 | 167 | 38 | 6 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-09 | 171 | 38 | 6 | d2a10e94b0490120d1420b944302eb841f902c64 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.64e-09 | 174 | 38 | 6 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.64e-09 | 174 | 38 | 6 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.64e-09 | 174 | 38 | 6 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.19e-09 | 176 | 38 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.19e-09 | 176 | 38 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.19e-09 | 176 | 38 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-09 | 181 | 38 | 6 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-09 | 181 | 38 | 6 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-09 | 181 | 38 | 6 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-08 | 182 | 38 | 6 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-08 | 183 | 38 | 6 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-08 | 185 | 38 | 6 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| Computational | Genes in the cancer module 68. | 2.75e-20 | 26 | 30 | 10 | MODULE_68 | |
| Computational | Keratin. | 2.75e-20 | 26 | 30 | 10 | MODULE_298 | |
| Computational | Genes in the cancer module 153. | 2.30e-14 | 34 | 30 | 8 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.60e-13 | 50 | 30 | 8 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Intermediate filaments and MT. | 8.80e-12 | 68 | 30 | 8 | MODULE_438 | |
| Computational | Intermediate filaments and keratins. | 1.72e-09 | 80 | 30 | 7 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.72e-09 | 80 | 30 | 7 | MODULE_297 | |
| Computational | Developmental processes. | 1.90e-07 | 333 | 30 | 9 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.32e-07 | 50 | 30 | 5 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.32e-07 | 50 | 30 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Genes in the cancer module 533. | 6.78e-06 | 45 | 30 | 4 | MODULE_533 | |
| Computational | Neighborhood of SPRR1B | 3.82e-05 | 24 | 30 | 3 | GNF2_SPRR1B | |
| Computational | Intermediate filaments. | 5.22e-05 | 75 | 30 | 4 | MODULE_154 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes in the cancer module 322. | 5.74e-04 | 59 | 30 | 3 | MODULE_322 | |
| Computational | Genes in the cancer module 98. | 6.47e-04 | 393 | 30 | 6 | MODULE_98 | |
| Computational | Neighborhood of DDX5 | 7.63e-04 | 65 | 30 | 3 | GCM_DDX5 | |
| Computational | Genes in the cancer module 111. | 8.11e-04 | 153 | 30 | 4 | MODULE_111 | |
| Computational | Genes in the cancer module 198. | 1.37e-03 | 303 | 30 | 5 | MODULE_198 | |
| Computational | Genes in the cancer module 342. | 2.74e-03 | 213 | 30 | 4 | MODULE_342 | |
| Computational | Neighborhood of TPR | 3.55e-03 | 32 | 30 | 2 | GCM_TPR | |
| Drug | teleocidin B | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 6.28e-34 | 123 | 38 | 19 | CID000072425 |
| Drug | sulfur mustard | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.94e-33 | 130 | 38 | 19 | CID000010461 |
| Drug | homocysteine thiolactone | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 2.27e-33 | 131 | 38 | 19 | CID000107712 |
| Drug | al-Badry | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 2.38e-31 | 165 | 38 | 19 | CID000004545 |
| Drug | AC1L9MJT | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 5.97e-28 | 192 | 38 | 18 | CID000448959 |
| Drug | Velcade (bortezomib | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 FUS KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 3.16e-26 | 374 | 38 | 20 | CID000093860 |
| Drug | 1-2q | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.15e-24 | 289 | 38 | 18 | CID000011820 |
| Drug | butyrate | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B TEAD2 KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C FXR2 KRT77 | 1.53e-21 | 767 | 38 | 21 | CID000000264 |
| Drug | adenosine 3',5'-cyclic phosphate | SHANK1 KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C SRGN KRT77 | 4.88e-20 | 907 | 38 | 21 | CID000000274 |
| Drug | dithranol | 1.18e-18 | 18 | 38 | 8 | CID000002202 | |
| Drug | olomoucine II | 5.94e-17 | 27 | 38 | 8 | CID005494414 | |
| Drug | NSC34533 | 1.82e-16 | 54 | 38 | 9 | CID000003512 | |
| Drug | phorbol acetate myristate | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C SRGN KRT77 | 5.97e-15 | 1399 | 38 | 20 | CID000004792 |
| Drug | ethylnylestradiol | KRT1 KRT2 KRT3 KRT4 KRT6A KRT6B KRT9 KRT10 KRT12 KRT13 KRT14 KRT76 KRT24 KRT15 KRT16 KRT75 KRT17 KRT6C KRT77 | 1.30e-14 | 1251 | 38 | 19 | CID000003285 |
| Drug | CK 6 | 4.94e-14 | 58 | 38 | 8 | CID000447960 | |
| Drug | phenyl isocyanate | 5.90e-14 | 6 | 38 | 5 | ctd:C025319 | |
| Drug | SC-791 | 5.90e-14 | 6 | 38 | 5 | CID010291510 | |
| Drug | clobestasol propionate | 1.74e-13 | 17 | 38 | 6 | CID000002791 | |
| Drug | chrysarobin | 1.99e-13 | 37 | 38 | 7 | CID000068111 | |
| Drug | Divonex | 2.13e-13 | 69 | 38 | 8 | CID000002522 | |
| Drug | Olux | 5.44e-13 | 20 | 38 | 6 | CID000032797 | |
| Drug | cignolin | 4.39e-12 | 56 | 38 | 7 | CID000010187 | |
| Drug | CK17 | 5.00e-12 | 57 | 38 | 7 | CID000128831 | |
| Drug | betamethasone valerate | 5.24e-12 | 28 | 38 | 6 | CID000016533 | |
| Drug | 4-oxoretinoic acid | 4.44e-11 | 77 | 38 | 7 | CID006437063 | |
| Drug | K-11 | 6.01e-11 | 17 | 38 | 5 | CID000469667 | |
| Drug | NSC134723 | 9.87e-11 | 6 | 38 | 4 | CID000281830 | |
| Drug | AC1L1GT5 | 2.00e-10 | 95 | 38 | 7 | CID000003829 | |
| Drug | MK-6 | 4.09e-10 | 24 | 38 | 5 | CID005283547 | |
| Drug | 4-oxoretinoic acid | 7.73e-10 | 115 | 38 | 7 | ctd:C002202 | |
| Drug | bromovanin | 1.55e-09 | 127 | 38 | 7 | ctd:C515564 | |
| Drug | K-13 | 1.62e-09 | 31 | 38 | 5 | CID000469669 | |
| Drug | 9-cis-acitretin | 1.89e-09 | 71 | 38 | 6 | CID000041317 | |
| Drug | 1pxm | 3.36e-09 | 78 | 38 | 6 | CID000447959 | |
| Drug | AC1L1KPQ | 3.36e-09 | 78 | 38 | 6 | CID000005602 | |
| Drug | liarozole | 5.44e-09 | 39 | 38 | 5 | CID000060652 | |
| Drug | CTFE | 1.28e-08 | 46 | 38 | 5 | CID000006594 | |
| Drug | mant-GTP | 1.98e-08 | 50 | 38 | 5 | CID000128647 | |
| Drug | JTV-519 | 1.98e-08 | 18 | 38 | 4 | CID000001715 | |
| Drug | Lh 1 | 4.72e-08 | 22 | 38 | 4 | CID000191841 | |
| Drug | PD153035 | 6.38e-08 | 127 | 38 | 6 | CID000004705 | |
| Drug | Bhg-(2-1)fuc | 8.14e-08 | 25 | 38 | 4 | CID005287784 | |
| Drug | antipsoriatic | 1.18e-07 | 71 | 38 | 5 | CID000005585 | |
| Drug | AC1NQZM2 | 1.52e-07 | 29 | 38 | 4 | CID005282177 | |
| Drug | benzalkonium | 1.58e-07 | 148 | 38 | 6 | CID000007681 | |
| Drug | bromodeoxyuridine | 1.63e-07 | 376 | 38 | 8 | CID000006035 | |
| Drug | 4-hydroxytestosterone | 1.90e-07 | 78 | 38 | 5 | CID000160615 | |
| Drug | 2-Formyl-Protoporphryn Ix | 2.01e-07 | 31 | 38 | 4 | CID011963946 | |
| Drug | AGN 193109 | 2.01e-07 | 31 | 38 | 4 | CID000177238 | |
| Drug | plakin | 2.45e-07 | 82 | 38 | 5 | CID000018752 | |
| Drug | AC1L9LMC | 2.60e-07 | 83 | 38 | 5 | CID000448113 | |
| Drug | CD367 | 2.61e-07 | 33 | 38 | 4 | CID000119342 | |
| Drug | sodium dodecyl sulfate | 4.13e-07 | 91 | 38 | 5 | CID000008778 | |
| Drug | I5B1 | 4.19e-07 | 37 | 38 | 4 | CID005487705 | |
| Drug | CaLam | 5.20e-07 | 39 | 38 | 4 | CID004126474 | |
| Drug | tazarotene | 5.77e-07 | 40 | 38 | 4 | CID000005381 | |
| Drug | alitretinoin | 5.85e-07 | 301 | 38 | 7 | ctd:C103303 | |
| Drug | calcipotriene | 7.01e-07 | 11 | 38 | 3 | ctd:C055085 | |
| Drug | chromium nitrate | 7.77e-07 | 43 | 38 | 4 | ctd:C041167 | |
| Drug | Mustard Gas | AAK1 KRT1 KRT6B KRT9 KRT10 KRT14 ILF3 KRT15 KRT16 KRT75 KRT17 TRO | 1.07e-06 | 1341 | 38 | 12 | ctd:D009151 |
| Drug | bexarotene | 1.11e-06 | 111 | 38 | 5 | CID000082146 | |
| Drug | Ro 13-6298 | 1.21e-06 | 13 | 38 | 3 | CID006437076 | |
| Drug | triphenyltin | 1.21e-06 | 13 | 38 | 3 | CID005357402 | |
| Drug | M50054 | 1.44e-06 | 117 | 38 | 5 | CID002748618 | |
| Drug | CD-III | 1.82e-06 | 53 | 38 | 4 | CID000066693 | |
| Drug | phenyl saligenin phosphate | 2.28e-06 | 56 | 38 | 4 | CID000104885 | |
| Drug | benzyl nicotinate | 2.71e-06 | 2 | 38 | 2 | CID000007191 | |
| Drug | isobutoxy | 2.71e-06 | 2 | 38 | 2 | CID000010557 | |
| Drug | DMBA | 3.49e-06 | 140 | 38 | 5 | CID000006001 | |
| Drug | N1-acetylspermidine | 4.79e-06 | 20 | 38 | 3 | CID000000496 | |
| Drug | Ak 2 | 5.59e-06 | 21 | 38 | 3 | CID006475484 | |
| Drug | 9,10-Dimethyl-1,2-benzanthracene | 5.85e-06 | 1046 | 38 | 10 | ctd:D015127 | |
| Drug | 1,4-pentanediamine | 7.36e-06 | 75 | 38 | 4 | CID000550880 | |
| Drug | 7-chloro-DL-tryptophan | 7.76e-06 | 76 | 38 | 4 | CID000643956 | |
| Drug | N8T | 8.13e-06 | 3 | 38 | 2 | CID006540271 | |
| Drug | Bi-E | 1.22e-05 | 27 | 38 | 3 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 1.37e-05 | 28 | 38 | 3 | CID011650719 | |
| Drug | CH2Cl | 1.37e-05 | 28 | 38 | 3 | CID005378701 | |
| Drug | potassiopotassium | 1.81e-05 | 94 | 38 | 4 | CID006432276 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 2547_DN | |
| Drug | N-(4-methoxyphenyl)retinamide | 1.87e-05 | 31 | 38 | 3 | ctd:C058346 | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 38 | 5 | 2514_UP | |
| Drug | 4,4'-thiodiphenol | 2.06e-05 | 32 | 38 | 3 | CID000017570 | |
| Drug | AC1L1JLU | 2.69e-05 | 104 | 38 | 4 | CID000005098 | |
| Drug | sulfisomidine | 2.70e-05 | 5 | 38 | 2 | CID000005343 | |
| Drug | tsuwabukinonol | 3.20e-05 | 37 | 38 | 3 | CID006440419 | |
| Drug | sodium chromate(VI) | 3.20e-05 | 37 | 38 | 3 | ctd:C028982 | |
| Drug | N-hydroxyurethane | 3.20e-05 | 37 | 38 | 3 | CID000011510 | |
| Drug | SKF-7261 | 3.48e-05 | 38 | 38 | 3 | CID000015773 | |
| Drug | Diethylstilbestrol | 3.99e-05 | 1305 | 38 | 10 | ctd:D004054 | |
| Drug | ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid | 4.05e-05 | 6 | 38 | 2 | ctd:C034814 | |
| Drug | Isotretinoin | 4.26e-05 | 799 | 38 | 8 | ctd:D015474 | |
| Drug | A805480 | 5.42e-05 | 44 | 38 | 3 | CID000620368 | |
| Drug | 2,4-diacetylphloroglucinol | 5.42e-05 | 44 | 38 | 3 | CID000016547 | |
| Drug | 3-buten-1-ol | 5.67e-05 | 7 | 38 | 2 | CID000069389 | |
| Drug | K 34 | 5.67e-05 | 7 | 38 | 2 | CID000281833 | |
| Drug | NSC339663 | 5.73e-05 | 250 | 38 | 5 | CID000003892 | |
| Drug | D-glucamine | 5.80e-05 | 45 | 38 | 3 | CID000027282 | |
| Drug | AC1L71LN | 6.07e-05 | 128 | 38 | 4 | CID000327966 | |
| Drug | AC1O0B8G | 7.15e-05 | 262 | 38 | 5 | CID000091605 | |
| Disease | Pachyonychia Congenita | 2.02e-15 | 5 | 36 | 5 | C0265334 | |
| Disease | Pachyonychia congenita syndrome | 1.87e-12 | 4 | 36 | 4 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.87e-12 | 4 | 36 | 4 | C1721007 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.87e-12 | 4 | 36 | 4 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.87e-12 | 4 | 36 | 4 | DOID:0050449 (is_implicated_in) | |
| Disease | Keratoderma, Palmoplantar | 8.75e-12 | 16 | 36 | 5 | C4551675 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 1.67e-09 | 3 | 36 | 3 | C1721006 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 1.67e-09 | 3 | 36 | 3 | C2931735 | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 1.67e-09 | 3 | 36 | 3 | C0343110 | |
| Disease | Leukokeratosis, Hereditary Mucosal | 1.45e-06 | 2 | 36 | 2 | C1721005 | |
| Disease | white sponge nevus (implicated_via_orthology) | 1.45e-06 | 2 | 36 | 2 | DOID:0050448 (implicated_via_orthology) | |
| Disease | Epidermolytic ichthyosis | 1.45e-06 | 2 | 36 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 1.45e-06 | 2 | 36 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 1.45e-06 | 2 | 36 | 2 | cv:C1843463 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 1.45e-06 | 2 | 36 | 2 | C3665704 | |
| Disease | Keratosis of Greither | 1.45e-06 | 2 | 36 | 2 | C2936837 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 1.45e-06 | 2 | 36 | 2 | C1843463 | |
| Disease | Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1.45e-06 | 2 | 36 | 2 | C0339277 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 1.45e-06 | 2 | 36 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 1.45e-06 | 2 | 36 | 2 | EFO_0021839 | |
| Disease | Palmoplantar keratoderma, epidermolytic | 1.45e-06 | 2 | 36 | 2 | cv:C1721006 | |
| Disease | Meesmann corneal dystrophy | 1.45e-06 | 2 | 36 | 2 | cv:C0339277 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 4.34e-06 | 3 | 36 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 4.34e-06 | 3 | 36 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | Hyperkeratosis, Epidermolytic | 1.44e-05 | 5 | 36 | 2 | C0079153 | |
| Disease | Squamous cell carcinoma | 1.58e-05 | 124 | 36 | 4 | C0007137 | |
| Disease | ectodermal dysplasia (is_implicated_in) | 3.03e-05 | 7 | 36 | 2 | DOID:2121 (is_implicated_in) | |
| Disease | Amyotrophic Lateral Sclerosis | 4.91e-05 | 58 | 36 | 3 | C0002736 | |
| Disease | Skin Neoplasms | 5.17e-05 | 59 | 36 | 3 | C0037286 | |
| Disease | Malignant neoplasm of skin | 5.17e-05 | 59 | 36 | 3 | C0007114 | |
| Disease | Contact hypersensitivity | 9.00e-05 | 71 | 36 | 3 | C0162351 | |
| Disease | Contact Dermatitis | 9.00e-05 | 71 | 36 | 3 | C0011616 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 9.48e-05 | 12 | 36 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 2.14e-04 | 95 | 36 | 3 | C0279626 | |
| Disease | sphingomyelin measurement | 3.58e-04 | 278 | 36 | 4 | EFO_0010118 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 6.16e-04 | 30 | 36 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | dihydroxy docosatrienoic acid measurement | 7.01e-04 | 32 | 36 | 2 | EFO_0005275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGGGGSTSGLGSGYI | 21 | Q2M2I8 | |
| RSSGGGYSGDRSGGG | 431 | Q92804 | |
| FGGGRSSCGFAGGYG | 81 | Q01546 | |
| GSGSGGYKGGSSSSS | 531 | Q01546 | |
| SSGYGVSGGSGSGYG | 546 | Q01546 | |
| VSGGSGSGYGGVSSG | 551 | Q01546 | |
| GSGYGGVSSGSTGGR | 556 | Q01546 | |
| GGGTGGFGTTSTFGQ | 11 | P52948 | |
| RAGGSYGFGGAGSGF | 86 | P48668 | |
| SYGSGLGIGGGFSSS | 516 | P48668 | |
| GFSSGGFSGGSFSRG | 46 | P13645 | |
| GFSGGSFSRGSSGGG | 51 | P13645 | |
| GGGSFRGSYGSSSFG | 81 | P13645 | |
| SSSFGGSYGGIFGGG | 91 | P13645 | |
| GSSSGGHGGSSSGGY | 516 | P13645 | |
| IGTASYGSGSGGSSG | 251 | O60299 | |
| YGSGSGGSSGGGSGY | 256 | O60299 | |
| SSVGSGYGGSAFGFG | 36 | Q99456 | |
| GYGGSAFGFGASCGG | 41 | Q99456 | |
| SMFGSSSGFGGGSGS | 61 | Q99456 | |
| GSGRGSGGSDKAGYS | 396 | P51116 | |
| FSSSYLSRSGGGGGG | 6 | P35527 | |
| SYSRFSSSGGGGGGG | 31 | P35527 | |
| SSSGGGGGGGRFSSS | 36 | P35527 | |
| GGGGGRFSSSSGYGG | 41 | P35527 | |
| GSGGGFSASSLGGGF | 76 | P35527 | |
| FSASSLGGGFGGGSR | 81 | P35527 | |
| GFGGASGGGYSSSGG | 96 | P35527 | |
| SGGGYSSSGGFGGGF | 101 | P35527 | |
| SGGSYGRGSRGGSGG | 481 | P35527 | |
| YGGGSGSRGGSGGSY | 506 | P35527 | |
| RAGGSYGFGGAGSGF | 86 | P02538 | |
| SYGSGLGVGGGFSSS | 516 | P02538 | |
| GGGYGGGFSSSSSSF | 66 | P02533 | |
| SSSSFGSGFGGGYGG | 76 | P02533 | |
| QSSMSSGGGSGGGYG | 181 | P35637 | |
| FGGGSSFGGGSGFSG | 96 | P35908 | |
| AAFGGSGGRGSSSGG | 516 | P35908 | |
| SGGRGSSSGGGYSSG | 521 | P35908 | |
| GSRGGSSSGGGYGSG | 601 | P35908 | |
| GGGRSSCAFAGGYGG | 81 | P12035 | |
| SCAFAGGYGGGFGSG | 86 | P12035 | |
| FGGGSSGFSGGSGFG | 576 | P12035 | |
| SGFSGGSGFGSISGA | 581 | P12035 | |
| LGSGSGFGLSSGFGS | 476 | P19013 | |
| GFGLSSGFGSGSGSG | 481 | P19013 | |
| SGFGSGSGSGFGFGG | 486 | P19013 | |
| GSGSGFGFGGSVSGS | 491 | P19013 | |
| QSSSASYGGGFGGGS | 6 | P13646 | |
| FVSGGSAGGYGGGVS | 36 | P13646 | |
| GSGGSSYGSGGGSYG | 526 | P04264 | |
| GGGRGSYGSGGSSYG | 546 | P04264 | |
| SYGSGGSSYGSGGGS | 551 | P04264 | |
| GSSYGSGGGSYGSGG | 556 | P04264 | |
| GSYGSGSSSGGYRGG | 576 | P04264 | |
| RAGGSYGFGGAGSGF | 86 | P04259 | |
| SYGSGLGVGGGFSSS | 516 | P04259 | |
| GGYGGGFSSSSSFGS | 66 | P08779 | |
| GFSSSSSFGSGFGGG | 71 | P08779 | |
| SSFGSGFGGGYGGGL | 76 | P08779 | |
| SLSGGSSGAFGGSFG | 51 | Q2M2I5 | |
| SSGAFGGSFGGGFGS | 56 | Q2M2I5 | |
| SGSGTGFGGGSSFGG | 81 | Q2M2I5 | |
| GFGGGSSFGGVSGFG | 86 | Q2M2I5 | |
| SSFGGVSGFGRGSGF | 91 | Q2M2I5 | |
| SCAFGGSSSAGGYGG | 46 | Q7Z3Y8 | |
| SGFSGFGSGTGGFSF | 2061 | P35658 | |
| FVSSGSGGGYGGGMR | 51 | P19012 | |
| HYSSFGSSGGSGGGS | 81 | Q7LFL8 | |
| YSFGSGGGYGSSFGG | 61 | Q04695 | |
| GSGGRSGGNSYGSGG | 811 | Q12906 | |
| SGGYGSGGYGGSANS | 1191 | Q08211 | |
| GSSNLGGFGTSSGFG | 506 | Q9BVL2 | |
| GAGGSISSGGFYGVS | 316 | Q15562 | |
| GSRAYGGGGGSSAFT | 1316 | Q9Y566 | |
| GGGGSSTGLAFGAFT | 351 | O95081 | |
| AGSASRSGFGGSGGG | 26 | Q9UKZ1 | |
| SAGFGGGLGTSAGFS | 1216 | Q12816 | |
| STGFGGGLGTSAGFS | 1256 | Q12816 | |
| SAGFSGGLGTSAGFG | 1266 | Q12816 | |
| EDYSGSGFGSGSGSG | 91 | P10124 | |
| SGGSRGYGSGGQGYG | 261 | P09651 | |
| GGSYGGSGRSGRGSS | 546 | Q7Z794 | |
| SGYGSGSSIGGGNLG | 481 | O95678 | |
| GGNLGLGGGSGYSFT | 491 | O95678 | |
| LGGGSGYSFTTSGGH | 496 | O95678 |